Condition
Benign Neoplasms
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02911064Active Not RecruitingPrimary
Expectations Regarding Mobility and Self-Care
NCT02810405Completed
Collection of Tissue Blocks or Slides From Patients With Cancer
NCT03042884Not ApplicableCompletedPrimary
Wearable Exercise Trackers in Cancer Rehabilitation
NCT00299195Not ApplicableCompleted
A Randomized Study of Sulindac in Oral Premalignant Lesions
NCT03429127UnknownPrimary
Normal Saline Vrs Balanced i.v. Fluids in Neurosurgery
Showing all 5 trials